These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20669252)

  • 1. Clozapine for medication-related pathological gambling in Parkinson disease.
    Rotondo A; Bosco D; Plastino M; Consoli A; Bosco F
    Mov Disord; 2010 Sep; 25(12):1994-5. PubMed ID: 20669252
    [No Abstract]   [Full Text] [Related]  

  • 2. Finasteride attenuates pathological gambling in patients with Parkinson disease.
    Bortolato M; Cannas A; Solla P; Bini V; Puligheddu M; Marrosu F
    J Clin Psychopharmacol; 2012 Jun; 32(3):424-5. PubMed ID: 22534502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].
    Miranda M; Slachevsky A; Bustamante L; Pérez C
    Rev Med Chil; 2010 Apr; 138(4):521-2. PubMed ID: 20668805
    [No Abstract]   [Full Text] [Related]  

  • 4. Is pathological gambling in Parkinson's disease reduced by amantadine?
    Lee JY; Kim HJ; Jeon BS
    Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathological gambling associated with pramipexole use in Parkinson's disease].
    Lester J; Gonzalez-Aleman G; Zuniga-Ramirez C; Diaz-Pascuali SP; Raina-Castellino GB; Micheli-Gould F
    Rev Neurol; 2006 Sep 1-15; 43(5):316-8. PubMed ID: 16941434
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 7. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
    Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
    Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological gambling caused by drugs used to treat Parkinson disease.
    Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE
    Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?
    Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C
    Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piribedil and pathological gambling in six parkinsonian patients.
    Micheli FE; Giugni JC; Espinosa ME; Calvo DS; Raina GB
    Arq Neuropsiquiatr; 2015 Feb; 73(2):115-8. PubMed ID: 25742580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 13. Quetiapine in a case with Parkinson disease and pathological gambling.
    Sevincok L; Akoglu A; Akyol A
    J Clin Psychopharmacol; 2007 Feb; 27(1):107-8. PubMed ID: 17224732
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 15. Impulse control disorders and pathological gambling in patients with Parkinson disease.
    Stamey W; Jankovic J
    Neurologist; 2008 Mar; 14(2):89-99. PubMed ID: 18332838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B; Montastruc JL
    Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
    [No Abstract]   [Full Text] [Related]  

  • 17. Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
    Ben-Shlomo Y; Lees A;
    Neurology; 2001 Jul; 57(2):369; author reply 369-70. PubMed ID: 11480425
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
    Katz KA; Cotsarelis G; Gupta R; Seykora JT
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs can trigger pathological gambling.
    Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.